Randomized Clinical Trial for the Prevention of SARS-CoV-2 Infection (COVID-19) in Healthcare Personnel

PHASE3CompletedINTERVENTIONAL
Enrollment

1,002

Participants

Timeline

Start Date

April 15, 2020

Primary Completion Date

February 25, 2021

Study Completion Date

July 11, 2021

Conditions
Coronavirus Infection
Interventions
DRUG

Emtricitabine/tenofovir disoproxil

Emtricitabine/tenofovir disoproxil, 200 mg/245 mg tablets. A dose of one tablet once a day will be administered.

DRUG

Hydroxychloroquine

Hydroxychloroquine, 200 mg tablets. A dose of one tablet once a day will be administered.

DRUG

Placebo: Emtricitabine/tenofovir disoproxil Placebo

Placebo: Tablets similar in appearance to Emtricitabine/tenofovir disoproxil

DRUG

Placebo: Hydroxychloroquine

Placebo: Tablets similar in appearance to Hydroxychloroquine

Trial Locations (65)

28034

Hospital Universitario Ramón y Cajal, Madrid

28905

Hospital de Getafe, Getafe

28935

Hospital de Móstoles, Móstoles

31500

Hospital Reina Sofía, Tudela

Unknown

Hospital Universitario de Ferrol, Ferrol

Hospital Clínico Universitario de Santiago, Santiago de Compostela

Hospital General de Elche, Elche

Hospital Sant Joan de Deu de Esplugues, Esplugues de Llobregat

Parc Sanitari Sant Joan de Déu de Sant Boi, Sant Boi de Llobregat

Hospital Infanta Margarita, Cabra

Hospital Insular de Las Palmas, Las Palmas de Gran Canaria

Hospital Universitario de Canarias, Las Palmas de Gran Canaria

Hospital de Donostia, San Sebastián

Hospital San Pedro, Logroño

Hospital Principe de Asturias, Alcalá de Henares

Hospital Fundación de Alcorcón, Alcorcón

Hospital Colllado Villalba, Collado Villalba

Hospital Severo Ochoa, Leganés

Hospital Rey Juan Carlos, Móstoles

Hospital Quirón Pozuelo, Pozuelo de Alarcón

Hospital de Torrejón, Torrejón de Ardoz

Hospital Infanta Elena, Valdemoro

Hospital Virgen del Castillo, Yecla

Hospital Costa del Sol, Marbella

Complejo Hospitalario de Navarra, Pamplona

Hospital Universitario Central de Asturias, Oviedo

Hospital Arnau de Vilanova, Llíria

Hospital de Araba, Alava

Hospital General Universitario de Albacete, Albacete

Hospital Nuestra Señora de Sonsoles, Ávila

Centro Médico Teknon, Barcelona

Hospital Clinic, Barcelona

Hospital del Mar, Barcelona

Hospital Dexeus, Barcelona

Hospital Quirón Barcelona, Barcelona

Hospital Universitario Sagrat Cor, Barcelona

Hospital Universitario de Burgos, Burgos

Hospital Virgen de la Luz, Cuenca

Hospital Clínico San Cecilio, Granada

Hospital Universitario de León, León

Fundación Jiménez Díaz, Madrid

Hospital Clinico San Carlos, Madrid

Hospital Infanta Leonor, Madrid

Hospital La Princesa, Madrid

Hospital Universitario 12 de Octubre, Madrid

Hospital Universitario Gregorio Marañon, Madrid

Hospital Universitario La Paz, Madrid

Hospital Universitario Puerta de Hierro, Madrid

Hospital Virgen de la Victoria, Málaga

Hospital Reina Sofía, Murcia

Hospital Universitario Virgen de la Arrixaca, Murcia

Complejo Asistencial de Palencia, Palencia

Hospital Universitario de Salamanca, Salamanca

Hospital General de Segovia, Segovia

Hospital Virgen del Rocio, Seville

Hospital Virgen Macarena, Seville

Hospital Clinico Universitario, Valencia

Hospital Dr. Peset, Valencia

Hospital General de Valencia, Valencia

Hospital La Fe, Valencia

Hospital de Valladolid, Valladolid

Hospital Rio Hortega, Valladolid

Hospital Lozano Blesa, Zaragoza

Hospital Miguel Servet, Zaragoza

08970

Hospital Moisès Broggi, Sant Joan Despí

All Listed Sponsors
collaborator

Effice Servicios Para la Investigacion S.L.

INDUSTRY

lead

Plan Nacional sobre el Sida (PNS)

OTHER_GOV

NCT04334928 - Randomized Clinical Trial for the Prevention of SARS-CoV-2 Infection (COVID-19) in Healthcare Personnel | Biotech Hunter | Biotech Hunter